Literature DB >> 7507843

Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth.

D Blanchard1, C Gaillard, P Hermann, J Banchereau.   

Abstract

In the present study, we examined the participation of CD40 ligand (L)-CD40 interaction in T cell-dependent B cell responses. To this end, purified B lymphocytes were cultured over irradiated CD4+ cloned T cells activated with immobilized anti-CD3 antibody. The anti-CD40 mAb 89 strongly blocked, in a specific fashion, both proliferation and Ig secretion of tonsil B cells. Interestingly, proliferation of surface (s)IgD+ B cell was significantly less inhibited by anti-CD40 than that of sIgD- cells. Preactivated T cells induced B cells to grow and secrete immunoglobulins preferentially in response to IL-2. This contrasts with the CD40 system where B cells are essentially responsive to IL-4 and IL-10 but not to IL-2 alone. Collectively, these data indicate that CD40L-CD40 interaction plays an important role in IL-2 mediated T cell-dependent B cell responses. However, the activation of a subset of sIgD+ cells may be independent of this interaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507843     DOI: 10.1002/eji.1830240209

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction.

Authors:  Sonia Néron; Claudia Racine; Annie Roy; Matthieu Guérin
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

2.  The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium.

Authors:  J Dechanet; P Merville; I Durand; J Banchereau; P Miossec
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

3.  Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

Authors:  Raphaël F Rousseau; Ettore Biagi; Aurélie Dutour; Eric S Yvon; Michael P Brown; Tiffany Lin; Zhuyong Mei; Bambi Grilley; Edwina Popek; Helen E Heslop; Adrian P Gee; Robert A Krance; Uday Popat; George Carrum; Judith F Margolin; Malcolm K Brenner
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

4.  Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.

Authors:  Steffanie Sabbaj; Robert F Pass; Paul A Goepfert; Sylvie Pichon
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

5.  Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.

Authors:  Susan Moir; Kisani M Ogwaro; Angela Malaspina; Joshua Vasquez; Eileen T Donoghue; Claire W Hallahan; Shuying Liu; Linda A Ehler; Marie A Planta; Shyamasundaran Kottilil; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

6.  Antibody-suppressor CD8+ T Cells Require CXCR5.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

7.  CD40-activated human naive surface IgD+ B cells produce IgG2 in response to activated T-cell supernatant.

Authors:  C Servet-Delprat; J M Bridon; D Blanchard; J Banchereau; F Brière
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

8.  Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.

Authors:  S Heidt; D L Roelen; C Eijsink; M Eikmans; C van Kooten; F H J Claas; A Mulder
Journal:  Clin Exp Immunol       Date:  2009-11-18       Impact factor: 4.330

9.  Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration.

Authors:  Anju Bansal; Bethany Jackson; Kim West; Shixia Wang; Shan Lu; Jeffrey S Kennedy; Paul A Goepfert
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

10.  Alloprimed CD8(+) T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms.

Authors:  J M Zimmerer; T A Pham; C L Wright; K J Tobin; P B Sanghavi; S M Elzein; V M Sanders; G L Bumgardner
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.